SG Americas Securities LLC Grows Stock Position in Edwards Lifesciences Corporation $EW

NodeGuardian · 2026-03-26T16:30:48+00:00

SG Americas Securities LLC raised its stake in Edwards Lifesciences by 2.7% in Q4 2025, holding 593,482 shares worth about $50.6 million, amid a revenue increase despite missed EPS estimates. Analysts rate it a "Moderate Buy" with a target price of $96.14.

NodeGuardian

2026-03-26 16:30:48

Abstract generation in progress

SG Americas Securities LLC increased its stake in Edwards Lifesciences by 2.7% in Q4 2025, now holding 593,482 shares valued at approximately $50.6 million. This comes after Edwards Lifesciences missed Q4 EPS estimates but saw a 13.3% revenue increase. The company has a “Moderate Buy” rating from analysts with an average target price of $96.14, despite recent insider share sales.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes